CA2500313C - Polymer composition and dosage forms comprising the same - Google Patents

Polymer composition and dosage forms comprising the same Download PDF

Info

Publication number
CA2500313C
CA2500313C CA2500313A CA2500313A CA2500313C CA 2500313 C CA2500313 C CA 2500313C CA 2500313 A CA2500313 A CA 2500313A CA 2500313 A CA2500313 A CA 2500313A CA 2500313 C CA2500313 C CA 2500313C
Authority
CA
Canada
Prior art keywords
dosage form
core
shell
polymer
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2500313A
Other languages
English (en)
French (fr)
Other versions
CA2500313A1 (en
Inventor
Jen-Chi Chen
Frank J. Bunick
Harry S. Sowden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/031024 external-priority patent/WO2003026625A1/en
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Priority claimed from PCT/US2003/008960 external-priority patent/WO2004028514A1/en
Publication of CA2500313A1 publication Critical patent/CA2500313A1/en
Application granted granted Critical
Publication of CA2500313C publication Critical patent/CA2500313C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2500313A 2002-09-28 2003-03-21 Polymer composition and dosage forms comprising the same Expired - Fee Related CA2500313C (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
USPCT/US02/31163 2002-09-28
PCT/US2002/031024 WO2003026625A1 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031117 WO2003026629A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
USPCT/US02/31117 2002-09-28
USPCT/US02/31024 2002-09-28
USPCT/US02/31129 2002-09-28
PCT/US2002/031129 WO2003026630A1 (en) 2001-09-28 2002-09-28 Dosage forms having an inner core and outer shell with different shapes
PCT/US2002/031163 WO2003026627A1 (en) 2001-09-28 2002-09-28 Composite dosage forms
USPCT/US02/31062 2002-09-28
PCT/US2002/031062 WO2003026626A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2003/008960 WO2004028514A1 (en) 2002-09-28 2003-03-21 Polymer composition and dosage forms comprising the same

Publications (2)

Publication Number Publication Date
CA2500313A1 CA2500313A1 (en) 2004-04-08
CA2500313C true CA2500313C (en) 2011-06-07

Family

ID=34271652

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002500311A Abandoned CA2500311A1 (en) 2002-09-28 2003-03-21 Modified release dosage forms
CA2500313A Expired - Fee Related CA2500313C (en) 2002-09-28 2003-03-21 Polymer composition and dosage forms comprising the same
CA002500312A Abandoned CA2500312A1 (en) 2002-09-28 2003-03-21 Modified release dosage form

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002500311A Abandoned CA2500311A1 (en) 2002-09-28 2003-03-21 Modified release dosage forms

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002500312A Abandoned CA2500312A1 (en) 2002-09-28 2003-03-21 Modified release dosage form

Country Status (8)

Country Link
JP (3) JP2006517514A (zh)
CN (3) CN1700907A (zh)
AT (1) ATE444739T1 (zh)
AU (4) AU2003225944A1 (zh)
BR (5) BR0314787A (zh)
CA (3) CA2500311A1 (zh)
DE (2) DE60329614D1 (zh)
MX (1) MXPA05003283A (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470463C (en) 2004-06-09 2012-09-18 Lornamead Brands, Inc. Tooth whitening products and methods of making the same
SA07280459B1 (ar) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP2011524891A (ja) * 2008-06-19 2011-09-08 ユニバーシティ・オブ・ジ・ウィトウォーターズランド・ヨハネスブルク 時間治療的医薬剤形
KR20130010464A (ko) * 2010-03-23 2013-01-28 아스카 세이야쿠 가부시키가이샤 고형 제제
WO2013009701A2 (en) * 2011-07-08 2013-01-17 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
WO2013119466A1 (en) * 2012-02-07 2013-08-15 Mcneil-Ppc, Inc. Rapidly disintegrating coated tablets
US9693962B2 (en) * 2012-06-05 2017-07-04 Takeda Pharmaceutical Limited Dry-coated tablet
CA2959186C (en) * 2014-09-19 2020-03-24 The Procter & Gamble Company Pulsed release phenylephrine dosage forms
KR20230079457A (ko) 2017-12-29 2023-06-07 락손 메디칼 아게 약물 전달 시스템
AU2022320730A1 (en) * 2021-07-30 2024-03-14 Evecxia Therapeutics, Inc. 5-hydroxytryptophan gastroretentive dosage forms
CN115295864B (zh) * 2021-11-09 2023-08-11 深圳市德方创域新能源科技有限公司 正极补锂添加剂及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662824A1 (en) * 1992-09-30 1995-07-19 Pfizer Inc. Article containing a core and a coating having a non constant thickness
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
WO2001078681A1 (fr) * 2000-04-17 2001-10-25 Yamanouchi Pharmaceutical Co., Ltd. Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant
ES2261643T3 (es) * 2001-02-13 2006-11-16 Astrazeneca Ab Nueva formulacion de liberacion modificada.

Also Published As

Publication number Publication date
AU2003220466A1 (en) 2004-04-19
JP2006517182A (ja) 2006-07-20
DE60335270D1 (de) 2011-01-20
AU2003218359A1 (en) 2004-04-19
JP2006517514A (ja) 2006-07-27
BR0314547A (pt) 2005-08-09
AU2003225944A1 (en) 2004-04-19
MXPA05003283A (es) 2005-11-23
CA2500313A1 (en) 2004-04-08
BR0314777A (pt) 2005-07-26
BR0314804A (pt) 2005-08-02
AU2003220472A1 (en) 2004-04-19
JP2006517183A (ja) 2006-07-20
BR0314787A (pt) 2005-07-26
CN1684671A (zh) 2005-10-19
CN1700908A (zh) 2005-11-23
CA2500311A1 (en) 2004-04-08
BR0314781A (pt) 2005-07-26
DE60329614D1 (de) 2009-11-19
CN1700907A (zh) 2005-11-23
CA2500312A1 (en) 2004-04-08
ATE444739T1 (de) 2009-10-15

Similar Documents

Publication Publication Date Title
US20080305150A1 (en) Polymer Composition And Dosage Forms Comprising The Same
EP1551374B1 (en) Polymer composition and dosage forms comprising the same
US7838026B2 (en) Burst-release polymer composition and dosage forms comprising the same
US20090186082A1 (en) Method of manufacturing modified release dosage forms
US20030228368A1 (en) Edible solid composition and dosage form
CA2500313C (en) Polymer composition and dosage forms comprising the same
WO2006049683A1 (en) Immediate release film coating
EP2811985B1 (en) Rapidly disintegrating coated tablets
US20030229158A1 (en) Polymer composition and dosage forms comprising the same
WO2006046954A1 (en) Burst-release polymer composition and dosage forms comprising the same
AU2002334735A1 (en) Dosage forms having an inner core and outer shell
MXPA05003281A (es) Formas de dosis de liberacion modificada con dos nucleos y una abertura.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190321